v3 Template
H

Hoba Therapeutics

Biotechnology ~220 employees
Founded
--
Employees (Est.)
~220
11 leaders known
Total Funding
$25.0M
Funding Rounds
1
Last Funding
2023-12-11

About Hoba Therapeutics

Hoba Therapeutics is an early-stage biotech company based in Denmark focused on developing innovative treatments for chronic pain disorders and sensorineural hearing loss, addressing high unmet medical needs for millions of patients worldwide.

Products & Services

HB-086:In late preclinical development for neuropathic pain, targeting indications such as CIPN and trigeminal neuralgia.
HB-097:In preclinical development for sensorineural hearing loss, targeting ototoxic hearing loss.

Specialties

Chronic pain disorders Sensorineural hearing loss Neurotrophic factors Therapeutic proteins

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A 		A: 25000000
MR: -
FA: EUR 23 million
FAN: 25000000 		D: 2023-12-11
FD: 2023-12-11 		6 investors
Series A Latest
2023-12-11
$25.0M
6 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

T

Torsten M. Madsen

CEO

K

Kenneth A Petersen

CDO and Founder

J

John Kemp

CSO

M

Mikkel Dybkjaer

CFO

J

Jean Combalbert

Chairperson

C

Camilla Petrycer Hansen

Principal

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

Hoba Therapeutics Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology
Company Size
~220 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro